Skip to main content
. Author manuscript; available in PMC: 2015 Jul 13.
Published in final edited form as: Curr Heart Fail Rep. 2012 Jun;9(2):107–116. doi: 10.1007/s11897-012-0089-5

Fig. 1.

Fig. 1

RAGE ligands-RAGE axis contributes to cardiac dysfunction and failure. The ligand-RAGE axis acts via both cell autonomous and cell non-autonomous mechanisms to enhance stress in the myocardium consequent to I/R, diabetes, or inflammation. We propose that the balance of RAGE action in these settings increases damage and blocks adaptive regeneration. Blockade of ligand-RAGE may be a targeted therapeutic strategy for strategies to salvage stressed myocardium. I/R ischemia/reperfusion; AGEs advanced glycation end products; HMGB1 high-mobility group protein B1; RAGE receptor for advanced glycation end products